File
DOJ
Document DOJ-OGR-00026234
AI Analysis
Summary: On July 12, 2019, Jeffrey Epstein requested a change in his constipation medication from Bisacodyl to Docusate Sodium (Colace). The change was approved and processed by a medical provider at the Metropolitan Correctional Center in New York (NYM).
Significance: This document provides insight into Jeffrey Epstein's medical treatment while incarcerated, specifically a change in his medication for constipation on July 12, 2019.
Key Topics:
Jeffrey Epstein's medical treatment
Medication change for constipation
Bureau of Prisons health services
Key People:
- Jeffrey Edward Epstein - Inmate receiving medical treatment